Detalles de la búsqueda
1.
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
Ann Oncol;
34(11): 970-986, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683978
2.
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Ann Oncol;
34(4): 397-409, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709040
3.
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
Ann Oncol;
32(10): 1216-1235, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34242744
4.
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Ann Oncol;
30(10): 1541-1557, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31373601
5.
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.
Ann Oncol;
28(2): 305-312, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27998961
6.
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Ann Oncol;
28(8): 1700-1712, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838210
7.
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Ann Oncol;
27(3): 379-90, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26681681
8.
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Ann Oncol;
26(8): 1533-46, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25939896
9.
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.
Ann Oncol;
26(12): 2442-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26387144
10.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol;
26(5): 873-879, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25725046
11.
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Ann Oncol;
30(7): 1181, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30624592
12.
Symptoms of endocrine treatment and outcome in the BIG 1-98 study.
Breast Cancer Res Treat;
143(1): 159-69, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24305979
13.
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Eur J Cancer;
200: 113535, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309015
14.
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
Ann Oncol;
24(9): 2206-23, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23917950
15.
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.
Ann Oncol;
24(5): 1203-11, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23293111
16.
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.
Ann Oncol;
29(1): 281-282, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29045519
17.
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Ann Oncol;
29(10): 2153, 2018 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29733336
18.
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.
Br J Cancer;
106(10): 1618-25, 2012 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22531635
19.
Absence of evidence is not evidence of absence: the case of non-inferiority.
Ann Oncol;
28(12): 3100-3101, 2017 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28945840
20.
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
Ann Oncol;
23(11): 2843-2851, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22707751